A Phase I, Open-Label, Dose Escalation and Cohort Expansion Study of BS HH 002.SA in Patients With AML and MDS

Clinical trial NCT04743115 · UNKNOWN

Trial details

NCT number: NCT04743115
Sponsor: Shanghai Bensen Pharmaceutical Co., Ltd.
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Acute Myeloid Leukemia, Myelodysplastic Syndrome

Start date: 2021-02-01
Primary completion: 2025-02-01
Enrollment: 66

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.